1. Decreased c-Abl activity in PC-3 and LNCaP prostate cancer cells overexpressing the early growth response-1 protein
   EDUARDO PARRA et al, 2014, Oncology Reports CrossRef
2. Clinical Significance of Immunogenic Cell Death Biomarker Rage and Early Growth Response 1 in Human Primary Gastric Adenocarcinoma
   X-C. Xu et al, 2013, International Journal of Immunopathology and Pharmacology CrossRef
3. Activation of Tax protein by c-Jun-N-terminal kinase is not dependent on the presence or absence of the early growth response-1 gene product
   EDUARDO PARRA et al, 2016, Oncology Reports CrossRef
4. Current status of CPT and its analogues in the treatment of malignancies
   Guohua Hu et al, 2015, Phytochemistry Reviews CrossRef
5. Assessment of Early Growth Response 1 in Tumor Suppression of Esophageal Squamous Cell Carcinoma
   Yen-Chiang Tseng et al, 2022, Journal of Clinical Medicine CrossRef
6. MicroRNA-181a-5p suppresses cell proliferation by targeting Egr1 and inhibiting Egr1/TGF-β/Smad pathway in hepatocellular carcinoma
   Jian-gang Bi et al, 2019, The International Journal of Biochemistry & Cell Biology CrossRef
7. EGR1 mediates MDR1 transcriptional activity regulating gemcitabine resistance in pancreatic cancer
   Zhe Yang et al, 2024, BMC Cancer CrossRef
8. Upregulated FGFR1 expression is associated with the transition of hormone-naive to castrate-resistant prostate cancer
   K Armstrong et al, 2011, British Journal of Cancer CrossRef
9. p300-Dependent ATF5 Acetylation Is Essential for Egr-1 Gene Activation and Cell Proliferation and Survival
   David X. Liu et al, 2011, Molecular and Cellular Biology CrossRef
10. siRNA and targeted delivery systems in breast cancer therapy
    Sepideh Mirzaei et al, 2022, Clinical and Translational Oncology CrossRef
11. Egr-1 enhances drug resistance of breast cancer by modulating MDR1 expression in a GGPPS-independent manner
    Weiwei Tao et al, 2013, Biomedicine & Pharmacotherapy CrossRef
12. Egr-1 is required for neu/HER2-induced mammary tumors
    Sunhwa Oh et al, 2018, Cellular Signalling CrossRef
13. Major regulators of the multi-step metastatic process are potential therapeutic targets for breast cancer management
    Alexandre Luiz Korte de Azevedo et al, 2023, Functional & Integrative Genomics CrossRef
14. Progress in Natural Compounds/siRNA Co-delivery Employing Nanovehicles for Cancer Therapy
    Milad Ashrafizadeh et al, 2020, ACS Combinatorial Science CrossRef
15. Egr-1 promotes hypoxia-induced autophagy to enhance chemo-resistance of hepatocellular carcinoma cells
    Wan-xin Peng et al, 2016, Experimental Cell Research CrossRef